The Spectrum Health Flow Cytometry Laboratory is pleased to announce that it has attained status as a Children’s Oncology Group (COG) approved laboratory for minimal residual disease (MRD) testing for patients with B lymphoblastic leukemia (B-ALL). This is a reflection of the expertise and dedication of the entire flow cytometry team to accomplish this 3-year project. It also highlights the strong support and collaboration between the laboratory and pediatric hematology oncology team.
We are the only COG approved flow cytometry laboratory in the state of Michigan, joining only 9 other approved US sites:
Spectrum Health Flow Cytometry
Lurie Children’s Hospital (Chicago)
Barnes Jewish Children’s (St. Louis)
Children’s Hospital of Los Angeles
Children’s Hospitals and Clinics of Minnesota
Intermountain Health Care (Utah)
Memorial Sloan Kettering Cancer Center (New York)
Seattle Children’s Hospital (Washington)
University of Washington
University of North Carolina Health Care
Johns Hopkins (Baltimore)
It should be noted that we are one of the few labs on the list that now has a COG approved Flow Lab as well as a COG approved Cytogenetics Lab. Congratulations to the whole team. Our dedication to patient-centered care shines brightly with this superb accomplishment!
Jennifer Stumph, M.D.
Associate Medical Director, Flow Cytometry
Spectrum Health Regional Laboratory – Advanced Technology Laboratories